The leading business intelligence provider, has released its latest research, “Biomarkers In Drug Discovery – Optimizing Drug Discovery Timeline and Costs”. The report provides an in-depth analysis of the potential applications of biomarkers in pharmaceutical drug discovery and clinical services. This pharmaceutical and healthcare report suggests investment decisions in biomarker-based drug research by providing information on valid biomarkers, pipelines, case studies, competitive landscape, geographical trends, mergers and acquisitions and market potential. It also provides an analysis on the trends prevailing in the global biomarkers market. In addition to this, the report covers drivers and restrains for the global biomarkers market.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts. Scope
The scope of this report includes: – Market Potential and Pipeline Analysis of biomarkers by phase of development, therapeutic class and geography. – Market Size and forecast of global biomarkers market and biomarkers drug discovery market from 2000 to 2008, forecast forward to 2015. – Analysis of Key geographies including the US (United States), Europe the UK (United Kingdom), France, Germany, Italy and Spain), Australia and Southeast Asia. – Investments and Funding Analysis for top companies (Quest Diagnostics, Applied Biosystems, Vermillion, BGMedical, Menarini, Abbott, Roche, Genetech, Affymetrix and Amgen) in the biomarker-based assay development arena. This includes biomarker research on the application and development of novel biomarkers by the top companies and analysis of the competitive factors affecting the global biomarkers market. – Qualitative analysis of market drivers, market trends, and challenges. – M&A landscape in the biomarkers space segmented by deal value, geography and phase. Reasons to buy
The report will improve decision making and will enable you to: – Develop business strategies by understanding the trends and developments that are driving the biomarkers-based drug research and development. – Design, develop and expand your product development, marketing and sales strategies based on forecast of global biomarkers and biomarkers drug discovery market till 2015 – Develop business strategies to exploit biomarkers-based drug discovery market in emerging geographies – Identify the key players positioned to take advantage of the emerging market opportunities – Exploit M&A opportunities by identifying key market players with the most novel pipeline
It is commonly asserted that in vitro diagnostics is a recession-proof industry. Kalorama Information’s lead diagnostic analyst Shara Rosen tests that assumption and provides strategic conclusions in Shara Rosen’s new report In Vitro Diagnostics in a Recession.
The economic problems that began slowing the U.S. economy keep spreading, with Europe and Japan following America into recession. The US is experiencing high unemployment rate and increased numbers of uninsured workers. But what impact is the downturn having on in vitro diagnostic companies? What are the best areas of IVD and the best world markets? How should companies price and market their products? What are key companies in the market doing at this time? Among the topics covered in this report: • Current Market Estimates for Major Categories of IVD. • Category Forecasts to 2014 • Hospital Woes, Uninsured Patients, Payor Stress, and Other Trends industry observers need to know about. • Current World Economic Conditions US, Europe and Emerging Markets • Obama Administration Healthcare Reform Boom or Bust for IVD? • Mergers and Acquisitions: Abbot – Ibis, QIAGEN – Corbett Life Science, J&J / Amic and several other competitive moves. • Collaborations: Luminex and BD Tripath, Geisinger Health System and Celera, Sysmex and Epigenomics and other partnerships enacted as companies pool limited resources. • Market Expansions: StatSensor Creatinine Meter (TM), Dako and BMS partnership and Others. • New Testing Products Launched: BD Focal Point, Aureon’s Prostate Px+, New Abbott Marker for AKI and other new tests. • Lab Service Commercialization Activities • Lab IT Activity and the Involvement of High Tech Players such as Google and IBM. • Success Strategies That are Working in 2009
Shara Rosen goes beyond just assessing the market and presents actions that IVD companies can take to assure growth in uncertain times. The report has a special focuses on developments in the United States since this is the largest single market for IVD products, but there is discussion of emerging world markets as well. The following companies who have engaged in relevant competitive activities in recent months were profiled in this report: • Abbott Diagnostics • Beckman Coulter Inc. • Becton, Dickinson and Company (BD) • bioMerieux Inc. • Celera Corporation • Cellestis Ltd • Cepheid • Clarient Inc. (formerly ChromaVision) • deCode Genetics Inc. • Genomic Health • Gen-Probe Inc. • Immucor, Inc. • Inverness Medical Innovations • Luminex Corporation • Monogram Biosciences, Inc. • Nanogen • Ortho Clinical Diagnostics (OCD) • Qiagen N.V. • Quidel Corporation • Roche Diagnostics • Seegene, Inc. • Sequenom, Inc. • Siemens Medical Solutions Diagnostics • Sysmex Corporation • Vermillion/Ciphergen Biosystems Inc.
This Kalorama Information report is a work of primary research. Although secondary sources were used, the analyst’s years of experience, interviews with industry experts and the latest findings of the 2009 Diagnostic Marketing Association Conference in Chicago IL were part of this report’s foundation.
It is commonly asserted that in vitro diagnostics is a recession-proof industry. Kalorama Information’s lead diagnostic analyst Shara Rosen tests that assumption and provides strategic conclusions in Shara Rosen’s new report In Vitro Diagnostics in a Recessionary Economy.
The economic problems that began slowing the U.S. economy keep spreading, with Europe and Japan following America into recession. The US is experiencing high unemployment rate and increased numbers of uninsured workers. But what impact is the downturn having on in vitro diagnostic companies? What are the best areas of IVD and the best world markets? How should companies price and market their products? What are key companies in the market doing at this time? Among the topics covered in this report:
Current Market Estimates for Major Categories of IVD.
Category Forecasts to 2014
Hospital Woes, Uninsured Patients, Payor Stress, and Other Trends industry observers need to know about.
Current World Economic Conditions US, Europe and Emerging Markets
Obama Administration Healthcare Reform Boom or Bust for IVD?
Mergers and Acquisitions: Abbot – Ibis, QIAGEN – Corbett Life Science, J&J / Amic and several other competitive moves.
Collaborations: Luminex and BD Tripath, Geisinger Health System and Celera, Sysmex and Epigenomics and other partnerships enacted as companies pool limited resources.
Market Expansions: StatSensor Creatinine Meter (TM), Dako and BMS partnership and Others.
New Testing Products Launched: BD Focal Point, Aureon’s Prostate Px+, New Abbott Marker for AKI and other new tests.
Lab Service Commercialization Activities
Lab IT Activity and the Involvement of High Tech Players such as Google and IBM.
Success Strategies That are Working in 2009
Shara Rosen goes beyond just assessing the market and presents actions that IVD companies can take to assure growth in uncertain times. The report has a special focuses on developments in the United States since this is the largest single market for IVD products, but there is discussion of emerging world markets as well. The following companies who have engaged in relevant competitive activities in recent months were profiled in this report:
Abbott Diagnostics
Beckman Coulter Inc.
Becton, Dickinson and Company (BD)
bioMerieux Inc.
Celera Corporation
Cellestis Ltd
Cepheid
Clarient Inc. (formerly ChromaVision)
deCode Genetics Inc.
Genomic Health
Gen-Probe Inc.
Immucor, Inc.
Inverness Medical Innovations
Luminex Corporation
Monogram Biosciences, Inc.
Nanogen
Ortho Clinical Diagnostics (OCD)
Qiagen N.V.
Quidel Corporation
Roche Diagnostics
Seegene, Inc.
Sequenom, Inc.
Siemens Medical Solutions Diagnostics
Sysmex Corporation
Vermillion/Ciphergen Biosystems Inc.
This Kalorama Information report is a work of primary research. Although secondary sources were used, the analyst’s years of experience, interviews with industry experts and the latest findings of the 2009 Diagnostic Marketing Association Conference in Chicago IL were part of this report’s foundation.
- The report provides information on the Israeli vitro diagnostics market, broken down into detailed categories and segments including In Vitro Diagnostics Devices, Clinical Chemistry Test Reagents, Immunochemistry Test Reagents, Blood Test Reagents, Microbiology Test Reagents, Infectious Immunology Test Reagents, Genetic Test Reagents, Self Testing, and Instruments. - Market shares of all the key competitors including F. Hoffmann-La Roche Ltd., Abbott Laboratories, Beckman Coulter, Inc., BioMerieux S.A., Ortho-Clinical Diagnostics Inc., and Siemens Medical Solutions, amongst others. - Key pipeline products that are set to shape the market, broken down by sector. - Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis. - Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement. - Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes. - Key mergers and acquisitions, partnerships, private equity investments and IPOs. - Customer, hospitals and physicians data.
Reasons to buy
- Gain a strong understanding of the in vitro diagnostics devices market in Israel. - Evaluate and compare the attractiveness of the market in the country. - Identify growth segments and opportunities in each industry sector within the country. - Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country. - Analyze the competitiveness of the market in the country and identify hotspots. - Develop strategies based on the latest product, brand, expansion and research and development news in the country. - Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country. - Identify and analyze the strengths and weaknesses of the industry incumbents in the country.
France In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015
Summary
This report is an essential source for in-depth information and data relating to France In vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in France
Scope
– The report provides information on the French in vitro diagnostics market, broken down into detailed categories and segments such as In Vitro Diagnostics, Clinical Chemistry Test Reagents, Immunochemistry Test Reagents, Blood Test Reagents, Microbiology Test Reagents, Infectious Immunology, Test Reagents, Genetic Test Reagents, Self Testing, and Instruments. – Total revenues, end users – Market shares of all the key competitors. – Key pipeline products that are set to shape the market, broken down by sector. – Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis. – Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement. – Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes. – Key mergers and acquisitions, partnerships, private equity investments and IPOs. – Customer, hospitals and physicians data.
Ventana Medical Systems, Inc. Sysmex Corporation Siemens Healthcare Qiagen N.V. Phadia AB Ortho-Clinical Diagnostics Inc. OLYMPUS CORPORATION Inverness Medical Innovations, Inc. Hologic, Inc. Gen-Probe Incorporated F. Hoffmann-La Roche Ltd. DiaSorin S.p.A Dade Behring Holdings, Inc. Bio-Rad Laboratories, Inc. bioMerieux S.A. Becton, Dickinson and Company Beckman Coulter, Inc. Abbott Laboratories Argene S.A. Biocode Hycel GEMAC S.A. ExonHit Therapeutics SA EUROMEDEX Diagnostica Stago The Elitech Group
Japan In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015
Summary
This report is an essential source for in-depth information and data relating to Japan In vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in Japan
Scope
– The report provides inforamtion on the Japanese in vitro diagnostics market, broken down into detailed categories and segments such as In Vitro Diagnostics, Clinical Chemistry Test Reagents, Immunochemistry Test Reagents, Blood Test Reagents, Microbiology Test Reagents, Infectious Immunology, Test Reagents, Genetic Test Reagents, Self Testing, and Instruments. – Total revenues, end users – Market shares of all the key competitors. – Key pipeline products that are set to shape the market, broken down by sector. – Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis. – Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement. – Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes. – Key mergers and acquisitions, partnerships, private equity investments and IPOs. – Customer, hospitals and physicians data.
F. Hoffmann-La Roche Ltd. Siemens Healthcare Sysmex Corporation Abbott Laboratories Beckman Coulter, Inc. Ortho-Clinical Diagnostics Inc. OLYMPUS CORPORATION Qiagen N.V. bioMerieux S.A. Bio-Rad Laboratories, Inc. Phadia AB DiaSorin S.p.A Becton, Dickinson and Company Gen-Probe Incorporated Inverness Medical Innovations, Inc. Hologic, Inc. Dade Behring Holdings, Inc. Eiken Chemical Co.,Ltd. Shionogi & Co., Ltd. Cosmo Bio Co., Ltd. Techno Medica Co., Ltd. HORIBA, Ltd. Kyowa Hakko Kirin Co., Ltd.
Australia In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015
Summary
This report is an essential source for in-depth information and data relating to Australia In vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in Australia
Scope
- The report provides information on the Australian in vitro diagnostics market, broken down into detailed categories and segments such as In Vitro Diagnostics, Clinical Chemistry Test Reagents, Immunochemistry Test Reagents, Blood Test Reagents, Microbiology Test Reagents, Infectious Immunology, Test Reagents, Genetic Test Reagents, Self Testing, and Instruments. - Total revenues, end users - Market shares of all the key competitors. - Key pipeline products that are set to shape the market, broken down by sector. - Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis. - Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement. - Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes. - Key mergers and acquisitions, partnerships, private equity investments and IPOs. - Customer, hospitals and physicians data.
Reasons to buy
- Gain a strong understanding of the in vitro diagnostics devices market in Australia. - Evaluate and compare the attractiveness of the market in the country. - Identify growth segments and opportunities in each industry sector within the country. - Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country. - Analyze the competitiveness of the market in the country and identify hotspots. - Develop strategies based on the latest product, brand, expansion and research and development news in the country. - Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country. - Identify and analyze the strengths and weaknesses of the industry incumbents in the country.
F. Hoffmann-La Roche Ltd. Siemens Healthcare Sysmex Corporation Abbott Laboratories Beckman Coulter, Inc. Ortho-Clinical Diagnostics Inc. OLYMPUS CORPORATION Qiagen N.V. bioMerieux S.A. Bio-Rad Laboratories, Inc. Phadia AB DiaSorin S.p.A Becton, Dickinson and Company Gen-Probe Incorporated Inverness Medical Innovations, Inc. Dade Behring Holdings, Inc. Ventana Medical Systems, Inc. Vision BioSystems Ltd Cellestis Limited GeneWorks Pty. Ltd. Astral Scientific Pty Ltd Enterix Australia Pty Ltd Cellabs Pty Ltd Diagnostic Technology Universal Biosensors, Inc. Panbio Limited
Germany In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015
Summary
This report is an essential source for in-depth information and data relating to Germany In vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in Germany
Scope
- The report provides information on the German in vitro diagnostics market, broken down into detailed categories and segments such as In Vitro Diagnostics, Clinical Chemistry Test Reagents, Immunochemistry Test Reagents, Blood Test Reagents, Microbiology Test Reagents, Infectious Immunology, Test Reagents, Genetic Test Reagents, Self Testing, and Instruments. - Total revenues, end users - Market shares of all the key competitors. - Key pipeline products that are set to shape the market, broken down by sector. - Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis. - Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement. - Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes. - Key mergers and acquisitions, partnerships, private equity investments and IPOs. - Customer, hospitals and physicians data.
Reasons to buy
- Gain a strong understanding of the in vitro diagnostics devices market in Germany. - Evaluate and compare the attractiveness of the market in the country. - Identify growth segments and opportunities in each industry sector within the country. - Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country. - Analyze the competitiveness of the market in the country and identify hotspots. - Develop strategies based on the latest product, brand, expansion and research and development news in the country. - Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country. - Identify and analyze the strengths and weaknesses of the industry incumbents in the country.
Ventana Medical Systems, Inc. Sysmex Corporation Siemens Healthcare Qiagen N.V. Phadia AB Ortho-Clinical Diagnostics Inc. OLYMPUS CORPORATION Inverness Medical Innovations, Inc. Hologic, Inc. Gen-Probe Incorporated F. Hoffmann-La Roche Ltd. DiaSorin S.p.A Dade Behring Holdings, Inc. Bio-Rad Laboratories, Inc. bioMerieux S.A. Becton, Dickinson and Company Beckman Coulter, Inc. Abbott Laboratories AdnaGen AG AMODIA Bioservice GmbH SIRS-Lab GmbH ACGT ProGenomics AG AnDiaTec GmbH & Co. KG BioRepair GmbH Biotest AG Scienion AG Invitek Biotechnolgy & Biodesign Ltd. ScheBo Biotech AG Serion Immundiagnostica GmbH Viramed Biotech AG MEDIPAN GmbH Epigenomics AG SARSTEDT AG & Co. BioCat GmbH 8sens.biognostic GmbH
Canada In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015
Summary
This report is an essential source for in-depth information and data relating to Canada In vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in Canada
Scope
– The report provides information on the Canadian in vitro diagnostics information, broken into detailed categories and segments such as In Vitro Diagnostics, Clinical Chemistry Test Reagents, Immunochemistry Test Reagents, Blood Test Reagents, Microbiology Test Reagents, Infectious Immunology, Test Reagents, Genetic Test Reagents, Self Testing, and Instruments. – Total revenues, end users – Market shares of all the key competitors. – Key pipeline products that are set to shape the market, broken down by sector. – Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis. – Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement. – Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes. – Key mergers and acquisitions, partnerships, private equity investments and IPOs. – Customer, hospitals and physicians data.
F. Hoffmann-La Roche Ltd. Siemens Healthcare Sysmex Corporation Abbott Laboratories Beckman Coulter, Inc. Ortho-Clinical Diagnostics Inc. OLYMPUS CORPORATION Qiagen N.V. bioMerieux S.A. Bio-Rad Laboratories, Inc. Phadia AB DiaSorin S.p.A Becton, Dickinson and Company Hologic, Inc. Gen-Probe Incorporated Inverness Medical Innovations, Inc. MedMira Inc. Affinity Biologicals Incorporated SQI Diagnostics Inc. Biocore Systems Inc. Biomedica Diagnostics Inc. Adaltis Inc. Cedarlane Laboratories Limited DRAXIMAGE Response Biomedical Corporation bioLytical Laboratories Inc. NuGen Biotech (Canada) Med BioGene Inc.
Aarkstore Enterprise is a leading provider of business and financial information and solutions worldwide. We specialize in providing online market business information on market research reports, books, magazines, conference at competitive prices, and strive to provide excellent and innovative service to our customers. Our customers include more than 700 leading financial institutions, professional service firms, consulting, law and accounting firms and other corporations throughout the world.
China Medical Equipment Market Analysis and Forecasts to 2015
This report provides key data, information and analysis on the China medical equipment markets. The report provides market landscape, competitive landscape and market trends information on 17 medical equipment markets. The report provides comprehensive information on the key trends affecting these markets, and key analytical insight on the market dynamics. The report also reviews the competitive landscape in terms of mergers and acquisitions, pipeline products and technology offerings. ( http://www.bharatbook.com/Market-Research-Reports/China-Medical-Equipment-Market-Analysis-and-Forecasts.html )
Scope
– Forecasts & Analysis of the China medical equipment market to 2015. – Market segmentation by cardiovascular devices, neurology devices, orthopedic devices, patient monitoring, anesthesia and respiratory devices, drug delivery devices, ENT devices, surgical equipment, dental devices, diabetes care devices, diagnostic imaging, endoscopy devices, hospital supplies, in vitro diagnostics, nephrology and urology devices, ophthalmic devices and wound care management. – Market Analysis from 2001 to 2008, including new updated 2008 data. – Analysis of the leading companies and competitive landscape including 2008 company market share analysis. Key companies covered include Siemens Medical Solutions, GE Healthcare, Philips Medical Systems, F. Hoffmann-La Roche Ltd, Johnson & Johnson Vision Care, Inc., Abbott Laboratories and Medtronic, Inc. – Analysis of key pipeline products, new technologies and clinical trials. – Insight into the key mergers and acquisitions (M&As), partnerships, venture capital and private equity investments. – Qualitative analysis of market drivers, market limiters regulatory issues and future outlook.
Reasons to buy
– Understand what the new growth opportunities are within China medical equipment market. – Develop a clear knowledge & understanding of the China medical equipment competitor landscape and how this will change to 2015. – Identify acquisition opportunities across the China medical equipment market. – Identify key winners and losers and who is best positioned to take advantage of the emerging market opportunities. – Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return. – Make more informed business decisions from the insightful and in-depth analysis of
Contact us at :
Bharat Book Bureau Tel: +91 22 27578668 Fax: +91 22 27579131 Email: info@bharatbook.com Website: www.bharatbook.com Blog: http://bharatbookresearch.blogspot.com
We are the leading information aggregator, facilitates and supports the business information needs. With over 115,000 reports, you can get instant access and insights on the studies in yo for market research , corporate / strategic planning by providing the latest information in the form of reports, journals, magazines and databases on varied industries like automotive, oil and gas, shipping, textiles, pharmaceuticals, energy, banking, finance, insurance, risk management, country intelligence, consumer & durable goods, chemical and more ur areas of interest. Contact us at +91 22 27578668 / 27579438 or email info@bharatbook.com or our website www.bharatbook.com
